Rich People Trades
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Rich People Trades

Politics

GOP, Dem senators remain divided over Medicaid after Trump’s ‘big, beautiful bill’ vote

by admin June 30, 2025
June 30, 2025
GOP, Dem senators remain divided over Medicaid after Trump’s ‘big, beautiful bill’ vote

Senate Republicans and Democrats remain divided on the Medicaid issue hours after President Donald Trump’s ‘big, beautiful bill’ passed a key Senate vote Saturday night.

Sen. Jim Banks, R-Ind., and Sen. Chris Coons, D-Del., both appeared on ‘Fox News Sunday’ to discuss Trump’s legislation in the wake of the 51-49 vote.

Banks argued that the Medicaid reforms would only affect certain people.

‘The Medicaid reforms would affect able-bodied Americans, those who are sitting at home who can work, who don’t work, who don’t have a sick kid or a sick mom, they shouldn’t receive Medicaid without working,’ he said. ‘And on top of that, the bill would take Medicaid away from illegal immigrants.’

Coons conceded there are states that are using their state funding to provide healthcare ‘for people who are undocumented,’ though argued that Trump’s $900 billion cuts to the program ‘are not about throwing people off of Medicaid who are not here legally.’

‘They are about imposing more and more requirements on the beneficiaries of Medicaid,’ the Democrat said.

Banks argued that taxes for everyday Americans will go up if the bill doesn’t get passed.

‘If we don’t pass this bill, everyone’s taxes on average will go up $2,000 a household, and that’s not fair to the regular Americans who work hard every day,’ he said.

Lingering concerns in both chambers about Medicaid — specifically the Medicaid provider tax rate and the effect of direct payments to states — energy tax credits, the state and local tax (SALT) deduction and others proved to be pain points that threatened the bill’s survival.

Coons, however, said that Americans who don’t believe the Democrats’ standpoint should listen to Sen. Tom Tillis, R-N.C., who, along with Sen. Rand Paul, R-Ky., voted against the bill.

‘Don’t believe me. Listen to Senator Tom Tillis,’ Coons said. ‘He’s been saying loudly this bill is a bad deal for the middle class. It’ll raise healthcare costs and throw millions off of needed health care.’

On Sunday morning, Trump slammed both Tillis and Paul on social media. 

Hours later, Tillis announced he would not seek reelection.

Following the vote, Minority Leader Chuck Schumer, D-N.Y., demanded that the text of the behemoth bill be read aloud before debates begin. After 14 hours, Senate clerks were still about 120 pages short of finishing reading aloud the 940-page text.

Once the reading is finished, the two parties will each get about 10 hours to debate on the bill. 

The timeline puts a likely Senate vote-a-rama on the bill in the early morning hours of Monday. A final passage vote could happen between late morning and late Monday night.

Fox News Digital’s Alex Miller and Fox News’ Tyler Olson contributed to this report.

This post appeared first on FOX NEWS

previous post
Tillis’ retirement announcement draws reactions from Trump critic Jeff Flake, Bernie Sanders: ‘A cult’
next post
Thom Tillis announces retirement from Senate after clash with Trump

Related Posts

House GOP elections chair reveals which voter blocs...

February 2, 2025

Former FBI Director James Comey meets with Secret...

May 17, 2025

Trump says public entitlements like Social Security, Medicaid...

May 1, 2025

Democratic lawmaker demands Musk, OPM stop sending mass...

February 28, 2025

US Embassy in Israel tells government employees, families...

June 15, 2025

Former Hamas hostage released 491 days after he...

February 9, 2025

Iran ramps up state executions amid nuclear talks...

April 23, 2025

‘All-in’: GOP lawmakers divided on US involvement as...

June 14, 2025

Schumer says ‘oligarchs’ keep him up at night,...

March 19, 2025

Trump’s ‘shock and awe’: Forget first 100 days,...

January 23, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      First lady Melania Trump’s new official portrait revealed

      January 28, 2025
    • 2

      Health experts prep Dem lawmakers on anti-vaccine arguments ahead of RFK Jr’s confirmation hearings

      January 28, 2025
    • 3

      ECOWAS pledges to ‘keep door open’ after 3 coup-hit West African nations exit regional bloc

      January 30, 2025
    • 4

      American fighters are dying in Ukraine in growing numbers. Bringing their bodies home is a complex task

      January 30, 2025
    • 5

      Vale Launches Strategic Review of Thompson Nickel Operations Amid Market Challenges

      January 28, 2025
    • 6

      Scorched-earth Shanahan: RFK Jr’s former running mate threatens political war against confirmation opponents

      January 30, 2025
    • 7

      Sparks expected to fly at Kash Patel’s Senate confirmation hearing to lead FBI

      January 30, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: richpeopletrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 richpeopletrades.com | All Rights Reserved